Protel’s Pharmaceutical project reporting extends throughout the UK, Ireland, France, Belgium and the Netherlands and covers all aspects of product development and manufacturing across the industry, including primary, secondary, biotech, OTC, medical devices and personal care products.
Projects range from plant upgrades and modifications to expansions and complete new builds, all with a breadth of scope to include a wide range of process equipment and associated services. Protel’s focus on the processing aspects of projects includes the production environment and ancillary services such as cleanrooms, HVAC, utilities, effluent treatment and laboratories.
Protel’s research team are currently investigating and tracking more than 350 active projects in the Pharmaceutical sector across c.230 sites, with a combined value in excess of £3.5 billion (€4.9bn).
One of the most important features of Protel’s project reporting is the inclusion of key decision makers and our Pharmaceutical projects database currently includes more than 1,600 contacts with roles encompassing:
- External consultants
- Technology providers
- EPC contractors
- Equipment specification & selection
- Project management
- Operations management